Vitality Biopharma Looks to Improve Cannabinoid Compounds

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
92
Vitality Biopharma Looks to Improve Cannabinoid Compounds -- CEO Interview with CFN Media

SEATTLE, WA--(Marketwired - Mar 1, 2017) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and video interview discussing the innovative work of Vitality Biopharma ( OTCQB : VBIO ).

Vitality Biopharma is focused on the discovery and production of cannabinoid glycosides for the treatment of serious neurological and inflammatory diseases. Small molecule glycosylation alters the solubility and stability of drug compounds, and it could extend patent life, improve bioavailability, and reduce side effects through targeted drug delivery. Applying this prodrug technology to cannabinoids may increase their efficacy in treating numerous medical conditions.

In 2013, the company initiated a research program to develop efficient means of glycosylation through enzymatic biosynthesis. By late 2015 and early 2016, the company's scientists applied this technology towards cannabinoids, including CBD and THC molecules, creating a new class of cannabinoid glycosides that it termed cannabosides . Since then, the company has filed patents covering over 20 cannabosides and started development on an inflammatory bowel disease (IBD) treatment.

According to Visiongain, the market for IBD treatments is expected to reach $9.3 billion by 2019, stimulated by rising disease incidence and non-invasive diagnosis, as well as technological advances in medicines.

Independent clinical trial data suggests that cannabis can induce remission even in patients that are resistant to steroids and biologic TNF-a inhibitors. In one eight-week placebo-controlled trial, there was a statistical change in the Crohn's Disease Activity Index with cannabis use, and nearly half of patients entered into disease remission. In another study of cannabis use in IBD patients, there were improvements reported by 83.9% of patients for abdominal pain and 76.8% for abdominal cramping, which means that an overwhelming majority reported symptomatic improvement.

Currently, most cannabis therapies must be low-dose since THC is absorbed in the blood-brain barrier. Vitality believes that its prodrug cannabosides could enable targeted delivery of THC molecules into the gut, which would enable higher local concentrations for pain and inflammation in the gastrointestinal tract. The company plans to begin Phase I/II studies this year while taking pathways that involve shorter trials through acute dosing regimens.

In the video interview, Vitality Biopharma CEO Robert Brooke talks about cannabosides, IBD, Vitality's federally-approved research facilities and practices, and the executive team.

Please follow the link to read the full article and see the interview: http://www.cannabisfn.com/vitality-biopharma-...compounds/

Learn how to become a CFN Media featured company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/

Download the CFN Media iOS mobile app to access the world of cannabis from your smart phone: https://itunes.apple.com/us/app/cannabisfn/id...?ls=1&mt=8

Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/ .

CFN Media Frank Lane 206-369-7050 flane@cannabisfn.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 83

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading
PEGATRON Unveils AI and HPC Advances at SC26

Updated Category News Views 38

Revamping AI with High-Density Computing You know, back in the day, AI was just about training models and running basic inference. But now, it's all about these crazy agentic AI tasks—autonomous agents doing things I couldn't have imagined. PEGATRON's Evolution in Infrastructure PEGATRON's latest move at SC26 is a real leap forward in this ongoing AI saga. They're...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 106

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 78

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 122

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 101

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
New York Reclaims Bagel Crown at 2026 BagelFest

Updated Category News Views 161

A Bagel Victory at Citi Field Holy schmear! New Yorker's are grinning wide like a bagel with a double helping of cream cheese—Ess-a-Bagel from Manhattan snagged the top honors at the heavily contested 2026 New York BagelFest. Back in its rightful hands, the Bagel Crown stays in the Empire State, and it's a victory for tradition and taste. Celebrating 50 years in the...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 142

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Pinot's Palette Expands with New La Quinta Studio

Updated Category News Views 79

Canvas and Cabernet in Coachella Valley Grab your brushes and wine glasses; Pinot's Palette is branching out to La Quinta. As of November 27, locals and visitors alike can find their artistic flair at 47120 Dune Palms Road. This move isn’t just another business expansion—it's about blending community spirit with creativity, backed by the experienced entrepreneurs...

Continue Reading
Mars Moves on Cash Tender Offers for Seniors' Notes

Updated Category News Views 104

A Strategic Financial Maneuver or a Casual Gambit? Okay, what’s Mars up to now, you ask? Here we go with this. The behemoth behind some of your favorite snacks and pet indulgences is making waves—not with candy, but with cash. Mars, Incorporated is rolling out tender offers to buy back a substantial chunk of its Senior Notes for $2 billion in cold, hard cash. When a...

Continue Reading

Top 5 Most Recently Viewed Articles

Highlights and Expectations for AAR's Upcoming Earnings Call

Updated Category News Views 102

AAR's Upcoming Earnings Release AAR (NYSE:AIR) is set to unveil its quarterly earnings report soon. Investors keenly await this announcement, hoping for positive surprises both in earnings and guidance for the future. Analysts’ Earnings Expectations Analysts predict that AAR will post an earnings per share (EPS) of $1.03. This figure reflects the optimism surrounding...

Continue Reading
Tradeweb Markets Reports Significant Trading Volume Growth

Updated Category News Views 218

Tradeweb Markets Sees Record Trading Volume in January Tradeweb Markets Inc. (NASDAQ: TW), a premier global provider of electronic marketplaces for trading various financial instruments, reported a phenomenal total trading volume of $54.6 trillion for January 2025. This figure represents an average daily volume (ADV) of approximately $2.44 trillion, showcasing a robust...

Continue Reading
Cal Water Celebrates EPA Recognition for Water Efficiency Efforts

Updated Category News Views 73

California Water Service, trading under NYSE: CWT, scored a big win back in 2024 when it snagged the U. S. Environmental Protection Agency’s (EPA) WaterSense Excellence in Promoting WaterSense Labeled Products Award for the second consecutive year. This ain't just fluff; it reflects a serious commitment to pushing water-efficient solutions that resonate with their...

Continue Reading
Navigating Market Trends: Key Earnings Week Insights

Updated Category News Views 125

Market Trends Before Earnings As we enter a pivotal earnings week, investors are feeling the pressure as tech stocks have led the way downwards. This anticipated decline comes as many anticipate significant corporate earnings that could either uplift or hamper the current record-setting rally in the markets. Stock Performance and Investor Sentiment On this busy Monday...

Continue Reading
Revolutionizing Insurance Research: The Game-Changer ZORRO Discover

Updated Category News Views 145

Introduction to ZORRO Discover ZestyAI has unveiled a groundbreaking tool aimed at transforming the insurance industry: ZORRO Discover. This innovative generative AI agent is set to revolutionize the way insurers handle regulatory filings and competitive market analysis, potentially reshaping operational strategies across the board. Significance of ZORRO Discover...

Continue Reading